Nicolò Rigamonti
- Immunology top 10%
- Immune cells in cancer 3
- Oncology top 10%
- Peptidase Inhibition and Analysis 4
- Cancer Immunotherapy and Biomarkers 3
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 2
-
- Ubiquitin and proteasome pathways 3
- Angiogenesis and VEGF in Cancer 2
-
- Adenosine and Purinergic Signaling 2
-
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Michele De PalmaEce KadiogluAnna KiialainenChia-Huey OoiMartina SchmittnaegelYvonne KienastDamya LaouiChing Ching Leow
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Cancer Research (4 papers)Clinical Cancer Research (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- SwitzerlandItalySweden
In The Last Decade
Nicolò Rigamonti
11 papers receiving 770 citations
Hit Papers
Peers
Comparison fields: 5 of 70
- Immunology 344
- Oncology 404
- Cancer Research 188
- Molecular Biology 375
- Hepatology 37
Countries citing papers authored by Nicolò Rigamonti
This map shows the geographic impact of Nicolò Rigamonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolò Rigamonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolò Rigamonti more than expected).
Fields of papers citing papers by Nicolò Rigamonti
This network shows the impact of papers produced by Nicolò Rigamonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolò Rigamonti. The network helps show where Nicolò Rigamonti may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nicolò Rigamonti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 18 | |
| 2 | 2021 | 1 | |
| 3 | 2020 | 1 | |
| 4 | 2019 | 1 | |
| 5 | 2018 | 1 | |
| 6 | Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockadebreakdown → | 2017 | 444 |
| 7 | 2014 | 180 | |
| 8 | 2012 | 17 | |
| 9 | 2011 | 22 | |
| 10 | 2009 | 91 | |
| 11 | 2009 | 4 |
About Nicolò Rigamonti
Nicolò Rigamonti is a scholar working on Physiology, Oncology and Immunology, having authored 11 papers that have together received 780 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Ubiquitin and proteasome pathways (3 papers), Immune cells in cancer (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Adenosine and Purinergic Signaling (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Immunology (344 citations), Oncology (404 citations) and Cancer Research (188 citations). Nicolò Rigamonti has collaborated with scholars based in Switzerland, Italy and Sweden. Frequent co-authors include Michele De Palma, Ece Kadioglu, Anna Kiialainen, Chia-Huey Ooi, Martina Schmittnaegel, Yvonne Kienast, Damya Laoui, Ching Ching Leow, Ioanna Keklikoglou and Matteo Bellone. Their work appears in journals such as Cancer Research, Clinical Cancer Research and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.